Citrate functionalized Mn<sub>3</sub>O<sub>4</sub> in nanotherapy of hepatic fibrosis by oral administration.

导出 LinkOut

翻译打印收藏纠错

作者： Aniruddha,Adhikari ^[1] ; Nabarun,Polley ^[1] ; Soumendra,Darbar ^[2] ; Damayanti,Bagchi ^[1] ; Samir Kumar,Pal ^[1]

作者单位： Department of Chemical, Biological & Macromolecular Sciences, S. N. Bose National Centre for Basic Sciences, Block JD, Sector III, Salt Lake, Kolkata 700106, India; Department of Chemical, Biological & Macromolecular Sciences, S. N. Bose National Centre for Basic Sciences, Block JD, Sector III, Salt Lake, Kolkata 700106, India. ^[1] Research & Development Division, Dey's Medical Stores (Mfg.) Ltd., 62, Bondel Road, Ballygunge, Kolkata 700019, India; Research & Development Division, Dey's Medical Stores (Mfg.) Ltd., 62, Bondel Road, Ballygunge, Kolkata 700019, India. ^[2]

关键词 fibrosis hepatoprotective nanomedicine nanotherapy oral administration of drug

DOI 10.4155/fsoa-2016-0029

PMID 28116129

发布时间 2020-10-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览28

Future science OA

2016年2卷4期

FSO146页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Citrate functionalized Mn<sub>3</sub>O<sub>4</sub> in nanotherapy of hepatic fibrosis by oral administration.

Future science OA

相似文献

Future science OA

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Citrate functionalized Mn<sub>3</sub>O<sub>4</sub> in nanotherapy of hepatic fibrosis by oral administration.

Future science OA

相似文献

Future science OA

相关期刊

检索历史清除